Brand Institute, Inc - Congratulations to AstraZeneca on the EMA approval of KYNTHEUM (brodalumab) for the treatment of adults with moderate-to-severe plaque psoriasis. #BIBrands #EMAapproval https://www.astrazeneca.com/media-centre/press-releases/2017 ...
![Schematic representation of the (A) FDA and (B) EMA approval pathways. | Download Scientific Diagram Schematic representation of the (A) FDA and (B) EMA approval pathways. | Download Scientific Diagram](https://www.researchgate.net/publication/316498449/figure/fig2/AS:490020705443842@1493841448575/Schematic-representation-of-the-A-FDA-and-B-EMA-approval-pathways.png)
Schematic representation of the (A) FDA and (B) EMA approval pathways. | Download Scientific Diagram
![Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014 | BMJ Open Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014 | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/6/6/e011666/F2.large.jpg)